Iain Kilty

Outlook Mobile Friendly Google Analytics Google Tag Manager Remote

biotechnology research immunometabolism cell metabolism disease-modifying therapies chronic inflammation autoimmune diseases inflamed tissue metabolic pathways immune regulation therapeutic targets immune cell function disease remission pyruvate kinase m2 activator gls1 inhibitor sik2 inhibitor biopharmaceutical company clinical development pipeline management cross-discipline expertise first-in-class drugs biomarkers in inflammation clinical trials pipeline innovations selective isozymes inhibitor development cancer immunotherapy patient outcomes drug discovery metabolic intervention chronic disease management anti-inflammatory agents partnering opportunities licensing strategies immunology research pharmacology inflammation resolution t lymphocyte modulation b lymphocyte activity therapeutic index research collaboration investor partnerships drug candidates clinical milestones autoimmune pathology senescent cell targeting chronic autoimmune pathologies collaboration with eli lilly patient-centric therapies drug development strategy key opinion leaders health care health wellness & fitness hospital & health care